EarlyTox Cell Viability Assay Kits

The EarlyTox™ cell viability assay kits are a family of fluorescence-based reagents for the assessment of cell viability, cell proliferation, and various apoptosis events using mammalian cells. Optimized for use with microplate readers, these assay kits employ a no-wash, homogeneous assay protocol that enables characterization of a full concentration-response profile of test compounds.

EarlyTox Cell Viability Assay Kits

Cell viability assays are critical to a broad spectrum of research areas ranging from investigation into the mechanisms of cell death to the development of new therapeutics targeting apoptosis in diseases. One of the most popular detection technologies for cell viability is a fluorescence microplate reader. The EarlyTox cell viability assay kits have been optimized for highly sensitive and accurate microplate detection which provides a complete solution for monitoring cell viability.

EarlyTox™ Live/Dead Assay Kit

This kit enables the detection of both the live and dead populations of mammalian cells based on the integrity of the cell membrane using a fluorescence microplate reader. Calcein AM is a widely used live-cell marker. The non-fluorescent calcein AM permeates the intact cell membrane and is converted into the fluorescent calcein by intracellular esterases. The number of live cells is therefore indicated by the intensity of green fluorescence in the cytosol, with excitation at 495 nm and emission at 530 nm. EthD-III is virtually non-fluorescent and impermeant to an intact plasma membrane. In the event of compromised cell membrane integrity that is associated with cell death, EthD-III enters cells and binds to nucleic acids, resulting in bright red fluorescence in dead cells, with excitation at 530 nm and emission at 645 nm.

EarlyTox™ Live Cell Assay Kit

This kit enables the detection of the live population of mammalian cells using a fluorescence microplate reader based on the integrity of the cell membrane and the intracellular esterase activity. Calcein AM is a widely used live-cell marker. The non-fluorescent calcein AM permeates the intact cell membrane and is converted into calcein, the fluorescent form, by intracellular esterases. The number of live cells is therefore indicated by the intensity of green fluorescence in the cytosol, with excitation at 495 nm and emission at 530 nm. The low cellular toxicity of calcein AM also enables long-term cell tracing and cell proliferation assay.

EarlyTox™ Caspase-3/7 R110 Assay Kit

This kit enables analysis of apoptosis based on caspase-3/7 activity and its consensus target sequence, Asp-Glu-Val-Asp (DEVD). Caspase-3 and caspase-7 are proteases that are activated during the execution phase of apoptosis. This kit provides a single-step, homogenous assay that is specifically designed for microplate readers. The fluorogenic substrate (Ac-DEVD)2-R110 contains two DEVD consensus target sequence and is completely hydrolyzed in cell lysate by the enzymes. Hydrolysis of both DEVD peptides releases the green fluorescent dye R110, resulting in a substantial fluorescence increase, with excitation at 490 nm and emission at 520 nm. The assay kit includes the competitive caspase-3/7 inhibitor Ac-DEVD-CHO for use as a negative control. R110 is also provided in the kit for generating a standard curve, which can be used for quantifying caspase-3 activity.

EarlyTox™ Caspase-3/7 NucView 488 Assay Kit and EarlyTox™ Caspase-3/7-D NucView 488 Assay Kit

This kit enables enable detection of apoptosis in intact cell populations based on the measurement of caspase-3/7 activity using either a fluorescence microplate reader or a fluorescence imaging system. Caspase-3 and caspase-7 are proteases that are activated during the execution phase of apoptosis. NucView 488 Caspase-3 substrate (formulated in DMSO or phosphate-buffered saline (PBS), for EarlyTox Caspase-3/7-D NucView 488 Assay Kit and EarlyTox Caspase-3/7 NucView 488 Assay Kit, respectively) is used to detect caspase-3/7 activity within intact cells without interfering with caspase activity. The substrate consists of a fluorogenic DNA dye that is coupled to the caspase-3/7 DEVD recognition sequence. Initially non-fluorescent, the substrate permeates the plasma membrane and enters the cytoplasm. In apoptotic cells, caspase-3/7 cleaves the substrate, releasing a high-affinity DNA dye that migrates to the cell nucleus and stains DNA with bright green fluorescence, with excitation at 500 nm and emission at 530 nm. NucView 488 staining is formaldehyde-fixable and compatible with subsequent immunostaining. The assay kit includes an optional masking reagent to reduce background fluorescence when necessary. The PBS formulation is recommended for cells that are sensitive to DMSO.

EarlyTox™ Glutathione Assay Kit

This kit enables the detection of an early apoptosis event based on the measurement of the glutathione content in live mammalian cells using a fluorescence microplate reader. Diminished cellular glutathione (GSH), which is an important anti-oxidant in mammalian cells, occurs at the early stages of mitochondria-associated apoptosis because of GSH efflux. This kit uses monochlorobimane (MCB), a cell permeant dye that has a high affinity for GSH, to detect the cellular GSH level in an apoptotic event. The unreacted dye is almost non-fluorescent. After reaction of the dye with GSH, catalyzed by endogenous glutathione-S-transferase (GST) enzymes, the dye fluoresces blue, with excitation at 394 nm and emission at 490 nm. The intensity of the fluorescence signal generated from the assay reflects the amount of GSH that is present in the cells.

Latest Resources

Data of EarlyTox Cell Viability Assay Kits

Ordering Options of EarlyTox Cell Viability Assay Kits

shopify-handles
earlytox-live-dead-assay-kit, earlytox-live-cell-assay-kit, earlytox-glutathione-assay-kit, earlytox-caspase-3-7-r110-assay-kit, earlytox-caspase-3-7-d-nucview-488-assay-kit, earlytox-caspase-3-7-nucview-488-assay-kit
#R8340
  • (1) vial of Calcein AM (4 mM, 30 µL)
  • (1) vial of EthD-III (2 mM, 60 µL)

Each kit contains enough material for two (2) 96-well or 384-well microplates.

#R8341
  • (3) vials of Calcein AM (4 mM, 50 µL)
  • (2) vials of EthD-III (2 mM, 150 µL)

Each kit contains enough material for ten (10) 96-well or 384-well microplates.

#R8342
  • (1) vial of Calcein AM (4 mM, 30 µL)

Each kit contains enough material for two (2) 96-well or 384-well microplates.

#R8343
  • (3) vials of Calcein AM (4 mM, 50 µL)

Each kit contains enough material for ten (10) 96-well or 384-well microplates.

#R8344
  • (1) vial of MCB (10 mM, 100 µL)

Each kit contains enough material for two (2) 96-well or 384-well microplates.

#R8345
  • (1) vial of MCB (10 mM, 500 µL)

Each kit contains enough material for ten (10) 96-well or 384-well microplates.

#R8346
  • (1) vial of Rhodamine 110 (80 µM, 1 mL)
  • (2) vials of caspase-3 inhibitor (5 mM, 20 µL)
  • (2) vials of DEVD-R110 (2 mM, 500 µL)
  • (2) vials of lysis buffer (10 mL)

Each kit contains enough material for two (2) 96-well or 384-well microplates.

#R8348
  • (1) vial of NucView 488 Caspase-3 Substrate in DMSO (1 mM, 200 µL)
  • (2) vials of masking reagent (1 vial/plate)

Each kit contains enough material for two (2) 96-well or 384-well microplates.

#R8350
  • (1) vial of NucView 488 Caspase-3 Substrate in PBS (1 mM, 200 µL)
  • (2) vials of masking reagent (1 vial/plate)

Each kit contains enough material for two (2) 96-well or 384-well microplates.

#R8351
  • (1) vial of NucView 488 Caspase-3 Substrate in PBS (1 mM, 1,000 µL)
  • (1) vial of masking reagent (1 vial/10 plates)

Each kit contains enough material for ten (10) 96-well or 384-well microplates.

Resources of EarlyTox Cell Viability Assay Kits

Compatible Products & Services of EarlyTox Cell Viability Assay Kits